Literature DB >> 26986924

Physiologically based pharmacokinetic model of docetaxel and interspecies scaling: comparison of simple injection with folate receptor-targeting amphiphilic copolymer-modified liposomes.

Xue-Feng Lu1, Kaishun Bi1, Xiaohui Chen1.   

Abstract

1. To compare the disposition of docetaxel (DTX) in male/female rats after intravenous administration of simple injection and folate-poly(PEG-cyanoacrylate-co-cholesteryl cyanoacrylate)-modified liposomes utilising a physiologically based pharmacokinetic (PBPK) modelling method, and extrapolate this model to mice and humans by taking into account the interspecies differences in physiological- and chemical-specific parameters. 2. Four structural models for single organs were evaluated, and the whole-body PBPK model included artery, vein, lung, brain, heart, spleen, liver, gastrointestinal tract, kidney, muscle and remainder compartment. 3. Rats following modified liposomes administration were characterised by significant decrease in the partition coefficients for brain, spleen, liver and remainder compartment. The blood-to-plasma partition coefficient also decreased significantly, while a marked rise of partition coefficients for lung, kidney and muscle was revealed. Partition coefficient for heart was approximately 1.3-fold higher in females than males, while the decrease of intestinal clearance was revealed in females compared to males. The final model successfully characterised the time course of DTX in rats, mice and humans. 4. This PBPK model is beneficial to the prediction of the effects of DTX in different species. It also represented a platform to encompass both formulation- and sex-related effects on DTX disposition and elimination in the future.

Entities:  

Keywords:  Biodistribution; docetaxel; folate-poly (PEG-cyanoacrylate-co-cholesteryl cyanoacrylate)-modified liposomes; interspecies scaling; physiologically based pharmacokinetic modelling

Mesh:

Substances:

Year:  2016        PMID: 26986924     DOI: 10.3109/00498254.2016.1155128

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  4 in total

1.  Isoflavones enhance pharmacokinetic exposure of active lovastatin acid via the upregulation of carboxylesterase in high-fat diet mice after oral administration of Xuezhikang capsules.

Authors:  Dong Feng; Chun Ge; Zhao-Yi Tan; Jian-Guo Sun; Yuan Xie; Lan Yao; Cai-Xia Yan; Ji-Ye Aa; Guang-Ji Wang
Journal:  Acta Pharmacol Sin       Date:  2018-06-19       Impact factor: 6.150

2.  Physiologically-based modeling and interspecies prediction of paclitaxel pharmacokinetics.

Authors:  Xiaowei Zang; Leonid Kagan
Journal:  J Pharmacokinet Pharmacodyn       Date:  2018-04-18       Impact factor: 2.745

3.  Utility of physiologically based pharmacokinetic (PBPK) modeling in oncology drug development and its accuracy: a systematic review.

Authors:  Teerachat Saeheng; Kesara Na-Bangchang; Juntra Karbwang
Journal:  Eur J Clin Pharmacol       Date:  2018-07-05       Impact factor: 2.953

Review 4.  Drug Exposure to Establish Pharmacokinetic-Response Relationships in Oncology.

Authors:  Belén P Solans; María Jesús Garrido; Iñaki F Trocóniz
Journal:  Clin Pharmacokinet       Date:  2020-02       Impact factor: 6.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.